Press Release Distribution
atherosclerosis Press Releases+ XML/RSS
By HEART CARE FOUNDATION OF INDIA
Women who have hypertension during pregnancy are at increased risk of developing atherosclerosis when they are older said Dr. K K Aggarwal
By homeopathy World Community
Health Inn internet TV & radio show host Debby Bruck interviews Dr Aadil, cardiologist on Monday April 29, 2013 at 11AM ET USA to learn about atherosclerosis / arteriosclerosis the epidemic of 21st century and Homeopathy
By Tersus Pharmaceuticals
Tersus Pharmaceuticals, a biopharmaceuticals firm in Cleveland, Ohio, developed the science behind Provinal™--an ultrapurified form of Omega 7 (Palmitoleic acid)--that has been shown to possess broad properties for cardiovascular health.
By SignaBlok, Inc.
SignaBlok, Inc., a Massachusetts-based biopharmaceutical startup, has been awarded a grant from the National Institutes of Health (NIH) to develop multifunctional nanoformulations for diagnostic imaging of atherosclerosis.
By David Eastman
Gamma Therapeutics, a biotech venture developing cardiac biomarkers, signed a mfg contract with ZEUS Scientific, one of the world’s leading mfgs. of autoimmune & infectious disease immunoassay kits & products for the clinical diagnostic industry.
By Dr.Victor Marchione
For natural health, few healing foods are as incredibly powerful as fish. Fish oil, high in omega-3 fats, spans an array of amazing health benefits. Any bit of health advice worth its own salt would mention fish as being part of the healthiest diet.
By Lightword Publishing
A dual university medical study links coronary heart disease, high blood pressure, COPD, and atherosclerosis to fine particle air pollution.
By Patrick Driscoll
Coronary artery disease treatments have faced a succession of new technology solutions that have led to the large, but now competitive drug-eluting stents market, but the success of developments continues with more challenges and opportunities.
By Patrick Driscoll
Treatment of coronary artery disease has become a hotbed for evaluation of an incredible range of alternatives, but drug-eluting stents (DES) clearly represent the most attractive option, according to a new report from MedMarket Diligence (MMD).
By Urmila Doraswami
Report Buyer, the online destination for business intelligence for major industry sectors, has added a new report which forecasts that cardiovascular disease will overtake infectious diseases to become the leading cause of death worldwide in 13 years